Published in Immunology on December 01, 1995
Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect Immun (1999) 1.12
Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner. Infect Immun (2003) 0.93
Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice. Infect Immun (1996) 0.88
Effects of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha on Trypanosoma cruzi trypomastigotes. Infect Immun (1998) 0.80
Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol (1980) 8.56
The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol (1990) 4.03
Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. J Immunol (1984) 3.72
Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods (1984) 2.38
Chagas' disease. Clin Microbiol Rev (1992) 2.30
Antigen-specific. I region-restricted interactions in vitro between tumor cell lines and T cell hybridomas. J Immunol (1982) 2.26
Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol (1991) 2.18
The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J Exp Med (1990) 1.64
A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody. J Immunol (1984) 1.58
Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. J Immunol (1993) 1.51
CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J Exp Med (1992) 1.36
Leishmania major interferes with antigen presentation by infected macrophages. J Immunol (1993) 1.35
Polyacrylamide-agarose beads for the preparation of effective immunoabsorbents. J Immunol Methods (1976) 1.25
T lymphocyte response to bacteriophage lambda repressor cI protein. Recognition of the same peptide presented by Ia molecules of different haplotypes. J Immunol (1987) 1.23
Peptide competition for antigen presentation. Immunol Today (1990) 1.14
Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen. Am Rev Respir Dis (1987) 1.07
Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J Immunol (1993) 1.06
Marked increase in Ia-bearing macrophages during Trypanosoma cruzi infection. Clin Immunol Immunopathol (1981) 0.97
Characterization and expression of proteases during Trypanosoma cruzi metacyclogenesis. Exp Parasitol (1991) 0.95
Trypanosoma cruzi but not Trypanosoma brucei fails to induce a chemiluminescent signal in a macrophage hybridoma cell line. Infect Immun (1991) 0.93
The peritoneal antigen-presenting macrophage: control and immunogenic properties of distinct subpopulations. Eur J Immunol (1981) 0.92
Trypanosoma cruzi upregulates nitric oxide release by IFN-gamma-preactivated macrophages, limiting cell infection independently of the respiratory burst. Parasite Immunol (1993) 0.92
Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody. Immunology (1990) 0.89
Differential antigen presentation by cloned populations of mouse splenic macrophages. J Immunol (1989) 0.83
Phagolysosomal escape by intracellular pathogens. Parasitol Today (1991) 0.82
Prostaglandins E as modulators of the immune response. Lymphokine Res (1988) 0.82
Mouse peritoneal macrophages: characterization of functional subsets following Percoll density gradients. Res Immunol (1993) 0.81
Influence of antigen processing on immune responsiveness. Immunol Today (1989) 0.79
Interferon-gamma-activated immature macrophages exhibit a high Trypanosoma cruzi infection rate associated with a low production of both nitric oxide and tumor necrosis factor-alpha. Parasitol Res (1994) 0.79
Organ-specific regulation of interferon-gamma, interleukin-2 and interleukin-2 receptor during murine infection with Trypanosoma cruzi. Scand J Immunol (1993) 0.79
Monoclonal c-myc transformed macrophage cell lines. I. Heterogeneity in ability to process and present antigen. J Immunol (1993) 0.77
Relationship between ineffective antigen presentation by murine alveolar macrophages and their immunosuppressive function. Immunology (1988) 0.77
Immunophenotyping of murine peritoneal macrophages and lymphocytes by flow cytometry. J Immunol Methods (1994) 0.77
Immunological self, nonself discrimination. Science (1987) 2.59
Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J Exp Med (1994) 2.50
Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science (1992) 2.41
Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature (1987) 2.34
Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. J Clin Invest (1999) 2.00
Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase. Proc Natl Acad Sci U S A (1980) 1.80
Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. J Virol (1998) 1.75
HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A (1998) 1.63
Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol (2001) 1.62
Solid phase cytometry for detection of rare events. Cytometry (1997) 1.61
Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine. J Virol (1998) 1.47
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol (1999) 1.41
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. J Clin Invest (1997) 1.39
Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur J Immunol (1995) 1.36
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. Lancet (1999) 1.35
Predominant involvement of CD8+CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activity. J Virol (1996) 1.35
Evidence for reversible microclustering of lentil lectin membrane receptors on HeLa cells. FEBS Lett (1980) 1.34
Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur J Immunol (1993) 1.29
Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum Gene Ther (1995) 1.27
Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol (1993) 1.25
T lymphocyte response to bacteriophage lambda repressor cI protein. Recognition of the same peptide presented by Ia molecules of different haplotypes. J Immunol (1987) 1.23
Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts. Eur J Immunol (1997) 1.18
T cell receptor gene usage in the response to lambda repressor cI protein. An apparent bias in the usage of a V alpha gene element. J Exp Med (1988) 1.17
Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol (2000) 1.17
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine. J Virol (2000) 1.14
Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect Immun (1999) 1.12
Characterization, serological specificity, and diagnostic possibilities of monoclonal antibodies against Legionella pneumophila. J Clin Microbiol (1983) 1.12
beta-Adrenergic agonist activity of a monoclonal anti-idiotypic antibody. Proc Natl Acad Sci U S A (1985) 1.11
Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. J Immunol (1992) 1.10
Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J Immunol (1998) 1.07
Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin Exp Immunol (1989) 1.07
Redistribution of muscarinic acetylcholine receptors on human fibroblasts induced by regulatory ligands. Biol Cell (1987) 1.06
Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J Immunol (1993) 1.06
Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers. AIDS (2001) 1.06
Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J Biol Chem (1996) 1.05
Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation. J Immunol (2001) 1.04
Localisation of three epitopes of the env protein of feline immunodeficiency virus. Mol Immunol (1992) 1.03
Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques. J Virol (1999) 1.02
Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo. J Invest Dermatol (2001) 1.02
Detection of phospholipase C in nontuberculous mycobacteria and its possible role in hemolytic activity. J Clin Microbiol (2001) 1.01
Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. Gene (1992) 1.00
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge. Virology (2000) 1.00
Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG- or NEF-specific cytotoxic T lymphocytes by lipopeptides. J Immunol (1994) 1.00
Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res (1999) 0.98
T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes. J Clin Immunol (1999) 0.98
CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation. Infect Immun (1999) 0.97
Identification in humans of HPV-16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA-B18 and determination of the HLA-B18-specific binding motif. Eur J Immunol (2000) 0.97
Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy. AIDS (1999) 0.96
Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression. AIDS Res Hum Retroviruses (1996) 0.96
Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects. Eur J Immunol (1999) 0.96
Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation. Eur J Immunol (2000) 0.96
Cancer and the heat shock response. Eur J Cancer (1994) 0.96
Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multirestricted lipopeptides. Vaccine (1995) 0.95
A simple assay for detection of peptides promoting the assembly of HLA class I molecules. Eur J Immunol (1994) 0.95
IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection. Clin Exp Immunol (1998) 0.94
Passive but not active CD8+ T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse model. J Immunol (1998) 0.93
Trypanosoma cruzi upregulates nitric oxide release by IFN-gamma-preactivated macrophages, limiting cell infection independently of the respiratory burst. Parasite Immunol (1993) 0.92
Identification of multirestricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein. J Virol (1994) 0.92
Monoclonal antibodies against the native or denatured forms of muscarinic acetylcholine receptors. EMBO J (1984) 0.92
Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides. Int Immunol (1996) 0.91
IFN-gamma receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide. J Immunol (1995) 0.91
Dissemination of SIV after rectal infection preferentially involves paracolic germinal centers. Virology (1999) 0.90
Altered ex vivo balance between CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients. Eur J Immunol (1999) 0.90
Antibodies from Trypanosoma cruzi infected mice recognize the second extracellular loop of the beta 1-adrenergic and M2-muscarinic receptors and regulate calcium channels in isolated cardiomyocytes. Mol Cell Biochem (1997) 0.90
HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding. Eur J Immunol (1995) 0.90
Influence of protein-quaternary structure on antigen processing. J Immunol (1993) 0.89
Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes. AIDS Res Hum Retroviruses (2001) 0.89
The immune response towards beta-adrenergic ligands and their receptors. VI. Idiotypy of monoclonal anti-alprenolol antibodies. J Immunol (1986) 0.89
Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol (1995) 0.89
Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS (1995) 0.89
Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice. Infect Immun (1996) 0.88
Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients. Hum Gene Ther (2000) 0.88
Biochemical and genetic evidence for phospholipase C activity in Mycobacterium ulcerans. Infect Immun (2000) 0.88
Functional analysis of rabbit anti-peptide antibodies which mimic autoantibodies against the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Autoimmun (1991) 0.88
Chicken cystatin stimulates nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages via cytokine synthesis. Eur J Biochem (1999) 0.88
Mutational analysis of ligand binding activity of beta 2 adrenergic receptor expressed in Escherichia coli. EMBO J (1990) 0.87
Preferential usage of the T-cell receptor by influenza virus hemagglutinin-specific human CD4+ T lymphocytes: in vitro life span of clonotypic T cells. J Virol (1995) 0.87
Adjuvant is required when using Env lipopeptide construct to induce HIV type 1-specific neutralizing antibody responses in mice in vivo. AIDS Res Hum Retroviruses (1998) 0.87
Time course of inducible nitric oxide synthase activity following endotoxin administration in dogs. Nitric Oxide (2001) 0.85
Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL. Vaccine (1996) 0.85
Induction of anti-phosphorylcholine antibodies of restricted heterogeneity in rabbits. Immunochemistry (1978) 0.85
Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi. Infect Immun (1987) 0.85
Relationship between granulocyte macrophage-colony stimulating factor, tumour necrosis factor-alpha and Trypanosoma cruzi infection of murine macrophages. Parasite Immunol (1995) 0.85
Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period. FEMS Immunol Med Microbiol (1997) 0.84
Lipopeptide presentation pathway in dendritic cells. Immunol Lett (2001) 0.84
Wheat germ agglutinin potentiates uptake of bacteria by murine peritoneal macrophages. Immunology (1984) 0.84
IFN-gamma-secreting Th cells regulate both the frequency and avidity of epitope-specific CD8+ T lymphocytes induced by peptide immunization: an ex vivo analysis. Int Immunol (1998) 0.84
Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies. Am J Med (1983) 0.84
Quantification of bacterial phagocytosis by flow cytometry and spectrofluorimetry. J Immunol Methods (1994) 0.84
Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules. Eur J Immunol (1995) 0.83
Localization and characterization of three different beta-adrenergic receptors expressed in Escherichia coli. Eur J Biochem (1990) 0.82
Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2. J Med Chem (1996) 0.82
Effects of alpha - and beta -adrenergic stimulation on hepatosplanchnic perfusion and oxygen extraction in endotoxic shock. Crit Care Med (2001) 0.82
Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: A mechanism of tumor immune escape in leukemia patients. Blood (1999) 0.82